What is the difference between Ozempic, Rybelsus, and Wegovy?

Ozempic (semaglutide), Rybelsus (semaglutide), and Wegovy (semaglutide) are GLP-1 medications used for weight management or type 2 diabetes. Key differences: Ozempic is FDA-approved, Rybelsus is FDA-approved, Wegovy is FDA-approved.

Which is most effective for weight loss: Ozempic, Rybelsus, or Wegovy?

Effectiveness varies by individual. In clinical trials, tirzepatide-based drugs (Mounjaro, Zepbound) produced ~22% average body-weight loss vs ~15% for semaglutide-based (Ozempic, Wegovy). Discuss with your prescriber.

Cash retail price: Ozempic $968/mo · Rybelsus $968/mo · Wegovy $1349/mo. Compounded versions through telehealth typically run 60-80% less.

3-way comparison

Ozempic vs Rybelsus vs Wegovy

Side-by-side breakdown — efficacy, cost, regulatory status, and who each option fits best.

Ozempic

semaglutide

Rybelsus

semaglutide

Wegovy

semaglutide

Side-by-side comparison

Attribute	Ozempic	Rybelsus	Wegovy
Generic name	semaglutide	semaglutide	semaglutide
Drug class	—	—	—
Regulatory status	FDA approved	FDA approved	FDA approved
Manufacturer	Novo Nordisk	Novo Nordisk	Novo Nordisk
Avg retail price	$968/mo	$968/mo	$1349/mo
Without insurance	$968–$1100/mo	$850–$1100/mo	$1349–$1500/mo
Savings card max	$25/mo	$10/mo	$0/mo
Shortage status

Ozempic vs Rybelsus vs Wegovy

Side-by-side comparison

FAQ

2-way head-to-heads

Already on one? Switching guides

None feel right? See alternatives